Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Jun;76(3):317–323.

Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals.

S Hashimoto 1, C C McCombs 1, J P Michalski 1
PMCID: PMC1541902  PMID: 2787712

Abstract

An important unanswered question in clinical immunology is why the histocompatibility antigens HLA-B8/DR3 should be associated with at least nine quite different immune-mediated diseases. The purpose of this study was to examine the mechanism of an immunologic abnormality, commonly found in healthy individuals with HLA-DR3, that may reflect an immune defect predisposing to autoimmunity. Fourteen healthy subjects with HLA-DR3 had a proliferative response to a suboptimal concentration of PHA nearly eight-fold lower than that observed in 10 individuals without this HLA antigen. Impaired responsiveness to PHA was more strongly associated with HLA-DR3 than with HLA-B8. The IL-2 concentration in mitogen-stimulated cultures was similarly decreased in subjects with HLA-DR3 and was highly predictive of the proliferative response 24 h later (r = 0.82, P less than 0.0001). Inhibition of IL-2 utilization by anti-IL-2 receptor antibody indicated that the reduced IL-2 concentration reflects impaired lymphokine production rather than increased utilization. Expression of IL-2 receptors is decreased in these subjects, although the magnitude of their proliferative response is appropriate for the available lymphokine. These results indicate that impaired lymphocyte activation associated with HLA-DR3 reflects impaired IL-2 production and an abnormality of activation events preceding the production of this lymphokine.

Full text

PDF
317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambinder J. N., Chiorazzi N., Gibofsky A., Fotino M., Kunkel H. G. Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type. Clin Immunol Immunopathol. 1982 May;23(2):269–274. doi: 10.1016/0090-1229(82)90113-1. [DOI] [PubMed] [Google Scholar]
  2. Bell J., Rassenti L., Smoot S., Smith K., Newby C., Hohlfeld R., Toyka K., McDevitt H., Steinman L. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet. 1986 May 10;1(8489):1058–1060. doi: 10.1016/s0140-6736(86)91330-9. [DOI] [PubMed] [Google Scholar]
  3. Bruserud O., Thorsby E. HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus. Studies of healthy individuals and patients with type 1 diabetes. Scand J Immunol. 1985 Nov;22(5):509–518. doi: 10.1111/j.1365-3083.1985.tb01910.x. [DOI] [PubMed] [Google Scholar]
  4. Davis J. E., Rich R. R., Van M., Le H. V., Pollack M. S., Cook R. G. Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency. J Clin Invest. 1987 Oct;80(4):998–1008. doi: 10.1172/JCI113194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Depper J. M., Leonard W. J., Drogula C., Krönke M., Waldmann T. A., Greene W. C. Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4230–4234. doi: 10.1073/pnas.82.12.4230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Depper J. M., Leonard W. J., Robb R. J., Waldmann T. A., Greene W. C. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. J Immunol. 1983 Aug;131(2):690–696. [PubMed] [Google Scholar]
  7. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  8. Goodwin J. S., Messner R. P., Williams R. C., Jr Inhibitors of T-cell mitogenesis: effect of mitogen dose. Cell Immunol. 1979 Jul;45(2):303–308. doi: 10.1016/0008-8749(79)90390-3. [DOI] [PubMed] [Google Scholar]
  9. Kupper T., Horowitz M., Lee F., Robb R., Flood P. M. Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell. J Immunol. 1987 Jun 15;138(12):4280–4287. [PubMed] [Google Scholar]
  10. Lawley T. J., Hall R. P., Fauci A. S., Katz S. I., Hamburger M. I., Frank M. M. Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects. N Engl J Med. 1981 Jan 22;304(4):185–192. doi: 10.1056/NEJM198101223040401. [DOI] [PubMed] [Google Scholar]
  11. Linker-Israeli M., Bakke A. C., Kitridou R. C., Gendler S., Gillis S., Horwitz D. A. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol. 1983 Jun;130(6):2651–2655. [PubMed] [Google Scholar]
  12. McCombs C. C., Michalski J. P. Lymphocyte abnormality associated with HLA-B8 in healthy young adults. J Exp Med. 1982 Sep 1;156(3):936–941. doi: 10.1084/jem.156.3.936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McCombs C. C., Michalski J. P., deShazo R., Bozelka B., Lane J. T. Immune abnormalities associated with HLA-B8: lymphocyte subsets and functional correlates. Clin Immunol Immunopathol. 1986 Apr;39(1):112–120. doi: 10.1016/0090-1229(86)90210-2. [DOI] [PubMed] [Google Scholar]
  14. McCombs C., Michalski J. P., Talal N. Cellular interactions in lymphocyte proliferation: effect of syngeneic and xenogeneic macrophages. Cell Immunol. 1976 May;23(2):283–296. doi: 10.1016/0008-8749(76)90194-5. [DOI] [PubMed] [Google Scholar]
  15. McKenna R., Stevens F. M., McNicholl B., Scholz S., Albert E., McCarthy C. F. Family and population studies of HLA and coeliac disease in the West of Ireland. Tissue Antigens. 1983 Sep;22(3):175–181. doi: 10.1111/j.1399-0039.1983.tb01188.x. [DOI] [PubMed] [Google Scholar]
  16. Michalski J. P., Bozelka B., Walter H. Subfractionation of human T lymphocyte subpopulations by partitioning: surface heterogeneity of the OKT8/Leu2+ T cell subset. Clin Exp Immunol. 1987 Mar;67(3):565–571. [PMC free article] [PubMed] [Google Scholar]
  17. Mizuochi T., Ono S., Malek T. R., Singer A. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens. J Exp Med. 1986 Mar 1;163(3):603–619. doi: 10.1084/jem.163.3.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Moriya N., Sanjoh K., Yokoyama S., Hayashi T. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes. J Immunol. 1987 Nov 15;139(10):3281–3286. [PubMed] [Google Scholar]
  19. Plater-Zyberk C., Rockett K. A., Maini R. N. Spontaneous recovery of the decreased expression in vitro of interleukin 2 receptors in rheumatoid arthritis. Clin Exp Immunol. 1988 Jul;73(1):93–97. [PMC free article] [PubMed] [Google Scholar]
  20. Robinson M. A., Kindt T. J. Molecular determination of T-cell receptor alpha and beta chain genotypes in human families. Hum Immunol. 1985 Nov;14(3):195–205. doi: 10.1016/0198-8859(85)90228-9. [DOI] [PubMed] [Google Scholar]
  21. Rood J. J., Hooff J. P., Keuning J. J. Disease predisposition, immune responsiveness and the fine structure of the HL-A supergene. A need for a reappraisal. Transplant Rev. 1975;22:75–104. doi: 10.1111/j.1600-065x.1975.tb01552.x. [DOI] [PubMed] [Google Scholar]
  22. Roosnek E. E., Brouwer M. C., Aarden L. A. T cell triggering by lectins. I. Requirements for interleukin 2 production; lectin concentration determines the accessory cell dependency. Eur J Immunol. 1985 Jul;15(7):652–656. doi: 10.1002/eji.1830150703. [DOI] [PubMed] [Google Scholar]
  23. Terasaki P. I., Bernoco D., Park M. S., Ozturk G., Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol. 1978 Feb;69(2):103–120. doi: 10.1093/ajcp/69.2.103. [DOI] [PubMed] [Google Scholar]
  24. Turco M. C., De Felice M., Corbo L., Morrone G., Mertelsmann R., Ferrone S., Venuta S. Regulatory role of a monomorphic determinant of HLA Class I antigens in T cell proliferation. J Immunol. 1985 Oct;135(4):2268–2273. [PubMed] [Google Scholar]
  25. Uchiyama T., Broder S., Waldmann T. A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol. 1981 Apr;126(4):1393–1397. [PubMed] [Google Scholar]
  26. Welte K., Andreeff M., Platzer E., Holloway K., Rubin B. Y., Moore M. A., Mertelsmann R. Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes. J Exp Med. 1984 Nov 1;160(5):1390–1403. doi: 10.1084/jem.160.5.1390. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES